Loading...
Please wait, while we are loading the content...
Similar Documents
Effectiveness of mailed letters to improve medication adherence among Medicare Advantage Plan participants with chronic conditions
| Content Provider | Scilit |
|---|---|
| Author | Mann, Amanda Esse, Tara W. Serna, Omar Castel, Liana D. Abughosh, Susan M. |
| Copyright Year | 2018 |
| Description | Journal: Patient preference and adherence |
| Abstract | Effectiveness of mailed letters to improve medication adherence among Medicare Advantage Plan participants with chronic conditions Amanda Mann,1 Tara W Esse,2 Omar Serna,2 Liana D Castel,3,4 Susan M Abughosh5 1Cigna-HealthSpring, Houston, TX, USA; 2CareAllies, Houston, TX, USA; 3Cigna Health and Life Insurance Company, Raleigh, NC, USA; 4Lundy-Fetterman School of Business, Campbell University, Buies Creek, NC, USA; 5Department of Pharmaceutical Health Outcomes and Policy, University of Houston College of Pharmacy, Houston, TX, USA Background: Medication adherence is associated with improved health outcomes in multiple chronic diseases. Information is needed on the effectiveness of specific adherence interventions. This study’s objectives were to quantify effects of a targeted mailing intervention on adherence among older adults at risk for nonadherence, and to examine associations of individual and plan characteristics with adherence. Materials and methods: Among adults enrolled in a Medicare Advantage Plan with prescription drug coverage from May 2014 to June 2015, those identified as eligible for the mailing intervention had a late refill for oral antidiabetic medication, statin, angiotensin-converting enzyme inhibitor, or angiotensin receptor blocker medication and were previously unreachable by telephone. Pharmacy claims data were analyzed with the outcome of 6-month proportion of days covered (PDC) before and after the mailing. The t-test and chi-square analyses were used to evaluate univariate associations. Multivariable linear and logistic regression models were conducted to assess relative covariate effects. A sub-analysis of those with at least one medication fill post-mailing was also performed. Results: A total of 460 non-adherent individuals aged 70±10.5 years, with 50.2% female and 66.7% white individuals, were included. Of those who were mailed a letter, 24.1% became adherent to the specified maintenance medication. Those who received >30-day supplies were more than twice as likely to become adherent after the mailed letter than those who received 30-day supplies or less (P<0.05). Baseline higher PDC was also associated with greater adherence post-mailing (P<0.01). A total of 284 (61.7%) individuals filled their medication at least once after the mailed letter; of those, 39.1% became adherent (mean [SD] change in PDC =0.15 [±0.28]). Conclusion: Our findings suggest that a single mailed letter improved medication adherence by 24.1% in adults with chronic conditions. As a health plan seeking to improve its customers’ well-being and outcomes, Cigna continues to utilize targeted mail interventions to improve medication adherence. Keywords: patient compliance, chronic disease, managed care programs, Medicare, Medicare Part D, Medicare Part C, mail distributions, population health, program evaluation |
| Related Links | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304824/pdf https://www.dovepress.com/getfile.php?fileID=47106 |
| Ending Page | 46 |
| Page Count | 10 |
| Starting Page | 37 |
| ISSN | 1177889X |
| DOI | 10.2147/ppa.s185848 |
| Journal | Patient preference and adherence |
| Volume Number | ume 13 |
| Language | English |
| Publisher | Informa UK Limited |
| Publisher Date | 2018-12-01 |
| Access Restriction | Open |
| Subject Keyword | Journal: Patient preference and adherence Public Health and Health Services Public, Environmental and Occupational Health Patient Compliance Chronic Disease Managed Care Programs Medicare Part D Medicare Part C Mail Distributions Population Health Program Evaluation |
| Content Type | Text |
| Subject | Social Sciences Pharmacology, Toxicology and Pharmaceutics Health Policy |
